| 2007 |
Acadia Pharmaceuticals |
Biotechnology |
$89 |
Follow On Equity Offering |
| 2007 |
Acorda Therapeutics |
Biotechnology |
$69 |
Follow On Equity Offering |
| 2007 |
Allos Therapeutics, Inc. |
Biotechnology |
$54 |
PIPE |
| 2007 |
Amylin Pharmaceuticals |
Biotechnology |
$500 |
Convertible Notes Offering |
| 2007 |
Array BioPharma, Inc. |
Biotechnology |
$91 |
Follow On Equity Offering |
| 2007 |
AstraZeneca |
Pharmaceuticals - Branded |
$3,000+ |
Investment Grade Bond Offering |
| 2007 |
Auxilium Pharmaceuticals |
Specialty Pharmaceuticals |
$53 |
PIPE |
| 2007 |
Biogen |
Biotechnology |
$400 |
Syndicated Bank Facility |
| 2007 |
Cambridge Heart |
Medical Devices/Supplies |
$13 |
PIPE |
| 2007 |
Epicept |
Biotechnology |
$10 |
PIPE |
| 2007 |
Globus Medical |
Medical Devices/Supplies |
$110 |
Private |
| 2007 |
Onyx Pharmaceuticals |
Biotechnology |
$185 |
Follow On Equity Offering |
| 2007 |
Pharmasset |
Biotechnology |
$45 |
IPO |
| 2007 |
Royalty Pharma |
Biotechnology |
$1,400 |
Syndicated Bank Facility |
| 2007 |
Solantic |
Providers - Alternate Site |
$40 |
Private |
| 2007 |
Vanda Pharmaceuticals |
Specialty Pharmaceuticals |
$104 |
Follow On Equity Offering |
| 2006 |
Acadia Pharmaceuticals |
Biotechnology |
$59 |
Follow On Equity Offering |
| 2006 |
Acorda Therapeutics |
Biotechnology |
$32 |
PIPE |
| 2006 |
Acorda Therapeutics |
Biotechnology |
$33 |
IPO |
| 2006 |
Akorn |
Specialty Pharmaceuticals |
$19 |
PIPE |
| 2006 |
Alnylam Pharmaceuticals |
Biotechnology |
$101 |
Follow On Equity Offering |
| 2006 |
Alnylam Pharmaceuticals |
Biotechnology |
$66 |
Follow On Equity Offering |
| 2006 |
Amarin Corporation |
Specialty Pharmaceuticals |
$19 |
PIPE |
| 2006 |
BioMS Medical |
Biotechnology |
$14 |
PIPE |
| 2006 |
Cerus |
Biotechnology |
$26 |
PIPE |
| 2006 |
Cerus Corporation |
Specialty Pharmaceuticals |
$26 |
Registered Direct |
| 2006 |
Columbia Laboratories |
Specialty Pharmaceuticals |
$30 |
PIPE |
| 2006 |
Cytogen |
Biotechnology |
$20 |
PIPE |
| 2006 |
Exelixis |
Biotechnology |
$84 |
Follow On Equity Offering |
| 2006 |
Genaera |
Biotechnology |
$25 |
Registered Direct |
| 2006 |
Genzyme Corporation |
Biotechnology |
$350 |
Syndicated Bank Facility |
| 2006 |
Gilead Sciences |
Biotechnology |
$1,300 |
Convertible Notes Offering |
| 2006 |
Ista Pharmaceuticals |
Specialty Pharmaceuticals |
$40 |
PIPE |
| 2006 |
Lexicon Genetics |
Biotechnology |
$40 |
PIPE |
| 2006 |
Medimmune |
Biotechnology |
$1,000 |
Convertible Notes Offering |
| 2006 |
Memory Pharmaceuticals |
Biotechnology |
$32 |
PIPE |
| 2006 |
Neorx (now Poniard Pharmaceuticals) |
Biotechnology |
$65 |
PIPE |
| 2006 |
Seattle Genetics |
Biotechnology |
$38 |
Follow On Equity Offering |
| 2006 |
Tech Pharmacy |
Outsourcing/Other Services |
$20 |
Private |
| 2006 |
Transave |
Biotechnology |
$35 |
Private Equity Placement |
| 2006 |
Trubion Pharmaceuticals |
Biotechnology |
$52 |
IPO |
| 2006 |
Vanda Pharmaceuticals |
Specialty Pharmaceuticals |
$58 |
IPO |
| 2005 |
Acadia Pharmaceuticals |
Biotechnology |
$36 |
PIPE |
| 2005 |
Amarin Corporation |
Specialty Pharmaceuticals |
$26 |
PIPE |
| 2005 |
Amylin Pharmaceuticals |
Biotechnology |
$176 |
Follow On Equity Offering |
| 2005 |
Dendreon [Corporation] |
Biotechnology |
$52 |
Follow On Equity Offering |
| 2005 |
Gilead Sciences |
Biotechnology |
$500 |
Syndicated Bank Facility |
| 2005 |
Memory Pharmaceuticals |
Biotechnology |
$31 |
PIPE |
| 2005 |
Momenta Pharmaceuticals |
Biotechnology |
$130 |
Follow On Equity Offering |
| 2005 |
Threshold Pharmaceuticals |
Biotechnology |
$37 |
IPO |
| 2004 |
Acadia Pharmaceuticals |
Biotechnology |
$35 |
IPO |
| 2004 |
Alnylam Pharmaceuticals |
Biotechnology |
$30 |
IPO |
| 2004 |
Curon Medical |
Medical Devices/Supplies |
$14 |
PIPE |
| 2004 |
InterMune Inc. |
Biotechnology |
$150 |
Convertible Notes Offering |
| 2004 |
Ista Pharmaceuticals |
Specialty Pharmaceuticals |
$13 |
PIPE |
| 2004 |
Memory Pharmaceuticals |
Biotechnology |
$35 |
IPO |
| 2004 |
Momenta Pharmaceuticals |
Biotechnology |
$35 |
IPO |
| 2004 |
Novavax |
Specialty Pharmaceuticals |
$35 |
PIPE |
| 2004 |
Orchid Biosciences |
Biotechnology |
$30 |
PIPE |
| 2004 |
Penwest Pharmaceuticals |
Specialty Pharmaceuticals |
$35 |
PIPE |
| 2004 |
Pharmasset |
Biotechnology |
$40 |
Private |
| 2004 |
Seattle Genetics |
Biotechnology |
$66 |
Follow On Equity Offering |
| 2004 |
Trigenesis |
Biotechnology |
$11 |
Private |
| 2003 |
Able Labs |
Specialty Pharmaceuticals |
$30 |
PIPE |
| 2003 |
Angiotech Pharmaceuticals |
Medical Devices/Supplies |
$252 |
Follow On Equity Offering |
| 2003 |
Chiron |
Biotechnology |
$500 |
Convertible Notes Offering |
| 2003 |
Hi-Tech Pharmacal |
Specialty Pharmaceuticals |
$25 |
PIPE |
| 2003 |
Isotechnika |
Biotechnology |
$15 |
PIPE |
| 2003 |
Neurochem |
Biotechnology |
$63 |
IPO (US) |
| 2003 |
Neurocrine |
Biotechnology |
$199 |
Follow On Equity Offering |
| 2003 |
Penwest Pharmaceuticals |
Specialty Pharmaceuticals |
$53 |
PIPE |
| 2002 |
Nuvelo |
Biotechnology |
$15 |
PIPE |
| 2002 |
Dynavax |
Biotechnology |
$35 |
Private |
| 2002 |
Regeneration Technologies |
Medical Devices/Supplies |
$28 |
PIPE |
| 2001 |
Triangle Pharmaceuticals |
Biotechnology |
$75 |
PIPE |
| 2001 |
Digirad |
Medical Devices/Supplies |
$14 |
Private |
| 2001 |
Triangle Pharmaceuticals |
Biotechnology |
$58 |
PIPE |
| 2000 |
Penwest Pharmaceuticals |
Specialty Pharmaceuticals |
$18 |
PIPE |